The White House has announced they support suspending the intellectual property rights on COVID-19 vaccine in order to increase vaccine production. This has surprised European Allies including Germany that have said they wouldn't like to cross that line. Other opponents say it won't help because ramping up production of vaccines is not based solely on the recipe but the raw materials available and the production facility capabilities. FOX's Trey Yingst speaks with Craig Singleton, of the Foundation for Defense of Democracies, about the announcement and what it may mean to vaccine production and the companies that developed their own.